Compare TECX & HQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | TECX | HQ |
|---|---|---|
| Founded | 2019 | 2018 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 618.9M | 674.1M |
| IPO Year | 2018 | 2025 |
| Metric | TECX | HQ |
|---|---|---|
| Price | $19.69 | $14.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 2 |
| Target Price | ★ $71.00 | $20.50 |
| AVG Volume (30 Days) | ★ 182.1K | 94.7K |
| Earning Date | 11-13-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 40.70 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.60 | $8.29 |
| 52 Week High | $39.53 | $45.00 |
| Indicator | TECX | HQ |
|---|---|---|
| Relative Strength Index (RSI) | 30.40 | 45.79 |
| Support Level | $16.77 | $13.68 |
| Resistance Level | $22.44 | $14.43 |
| Average True Range (ATR) | 1.08 | 1.11 |
| MACD | 0.16 | 0.06 |
| Stochastic Oscillator | 4.51 | 47.94 |
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
Horizon Quantum Holdings Ltd is building software infrastructure to make quantum computers accessible to commercial enterprises and hardware providers. By bridging the gap between hardware and applications, the company seeks to equip developers, researchers, and enterprises with the quantum software infrastructure needed to solve real-world problems. The company is developing tools that can automatically accelerate code written for conventional computers on quantum computers.